from 35 to 45 µg/ml. Moreover, the antimicrobial effects of compound 3 were more profound against fungal pathogens than against bacterial pathogens (minimal inhibitory concentrations; fungi, 0.08–0.14 mg/ml; bacteria, 0.3–1.4 mg/ml). These findings lay the foundation for designing improved bioactive agents that could be utilized as anticancer and/or antimicrobial agents.
需要开发安全有效的药物来治疗主要疾病,例如癌症和传染病。为响应这一需求,我们合成了一种新型的烯胺酮,其结构上属于烯胺酮基团接枝的
三硫代碳酸酯类。(G的抗癌和抗微
生物活性通过利用三种不同类型的人类癌症(
MDA-MB-231,株LoVo,和HepG2)和微
生物的宽视场的评价+和G -细菌,酵母和霉菌)。与所有检查的人类肿瘤细胞相比,受试化合物3表现出中等的生长抑制活性,IC 50值为35至45 µg / ml。此外,化合物3的抗菌作用对真菌病原体的抵抗力要强于对细菌病原体的抵抗力(最小抑菌浓度;真菌,0.08-0.14 mg / ml;细菌,0.3-1.4 mg / ml)。这些发现为设计改进的可用作抗癌和/或抗微
生物剂的
生物活性剂奠定了基础。